Background: Fibromyalgia (FM) is one of the most common causes of chronic widespread pain. It may negatively affect the lumbopelvic muscles, is an important part of the body, in FM patients due to chronic pain, fatigue, cytokines and immobility [1, 2]. However, the precise manner in which morphological properties of lumbopelvic muscles in patients with fibromyalgia (FM) are affected remains unclear.
Objectives: The aim of present study was to compare lumbopelvic muscle morphological properties evaluated with ultrasonographic (US) imaging in patients with FM and asymptomatic individuals and to examine the relationship between lumbopelvic muscle thickness and endurance, pain and fatigue.
Methods: Women with FM group (n: 53, age: 45.96±9.96 years), and asymptomatic control group (n: 49, age: 45.12±7.28), were included in this study. Pain severity, fatique, lumbopelvic muscle morphology and endurance were evaluated with the Visual Analogue Scale (VAS), Fatigue Severity Scale (FSS), US imaging and McGill core endurance tests, respectively.
Results: The lumbar multifidus (LM) and internal oblique muscle thicknesses, lumbopelvic muscle endurance were lower in FM group compared to the asymptomatic group (p<0.005). No statistically significant differences were found in other abdominal muscle thicknesses between the two groups (p>0.05) (Table 1). LM muscle thickness was significantly correlated with lumbopelvic muscle endurance, pain and fatique (p<0.001) (Table 2).
Conclusion: Lumbopelvic muscle thickness and endurance in FM patients have been affected negatively. Furthermore, lumbopelvic muscle thickness is associated with endurance, pain and fatique in patients with FM. These findings should be considered in management of FM.
REFERENCES: [1] Park JH, Niermann KJ, Olsen N. Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Current Rheumatology Reports 2000; 2(2): 131-140.
[2] Mirza Y, Küçük A. Association of Kinesiophobia with Core Muscle Endurance, Functional Mobility and Physical Activity Level in Patients with Fibromyalgia Syndrome: A Cross-Sectional Study. Mevlana Medical Sciences 2024; 4(2): 85–91.
Comparison of FM patients and healthy control
Parameters | FM group (n = 53) | Control group (n = 49) | p-value |
---|---|---|---|
Physical and demographic characteristics | |||
Age (years) | 45.96±9.96 | 45.12±7.28 | 0.581 a |
BMI (kg/m 2 ) | 29.37 (22.64/32.44) | 28.77 (25.45/31.66) | 0.451 b |
Clinical parameters | |||
Disease duration (years) | 5 (2/8) | - | - |
Painkiller use, n (%) | 35 (66) | - | - |
Pain (VAS) | 8 (5/8) | - | - |
FSS (score) | 4.88 (4/5.49) | - | - |
Lumbopelvic muscle thickness | |||
External Oblique (mm) | 4.75±1.06 | 4.93±0.96 | 0.385 a |
Internal Oblique (mm) | 4.76±1.02 | 5 (4.5/6.4) | 0.013 *b |
Transversus Abdominis (mm) | 3.85±0.78 | 3.89±0.96 | 0.801 a |
Lumbar Multifidus (mm) | 11.92±1.46 | 16.25 (15.42/18.37) | <0.001 **b |
Lumbopelvic muscle endurance | |||
Trunk flexor
| 8.73 (5.58/14.3) | 28.01 (23.63/30) | <0.001**b |
Trunk extensor
| 8.92 (5.73/12.57) | 29.54±2.89 | <0.001 **b |
Right trunk
| 10.5 (6.04/15.42) | 30 (30/30) | <0.001 **b |
Left trunk lateral
| 10.37 (6.66/14.85) | 30 (30/30) | <0.001 **b |
Independent sample t test, b Mann–Whitney U test, IQR 25/75: Interquartile range 25/75, M: mean, SD: standard deviation
FM: Fibromyalgia, BMI: Body-mass index, VAS: Visual Analog Scale, FSS: Fatigue Severity Scale
*p<0.05, **p<0.001.
Correlations between lumbopelvic muscle thickness and endurance and clinical features in FM patients
Lumbopelvic muscle thickness | ||||
---|---|---|---|---|
n: 53 | External Oblique | Internal Oblique | Transversus Abdominis | Lumbar Multifidus |
rho
| rho
| rho
| rho
|
|
Trunk flexor
| 0.270 | 0.368 | 0.272 | 0.429 |
0.051 | 0.007 | 0.049 | 0.001 | |
Trunk extensor
| 0.215 | 0.250 | 0.249 | 0.389 |
0.122 | 0.071 | 0.072 | 0.004 | |
Right trunk
| 0.297 | 0.319 | 0.111 | 0.394 |
0.031 | 0.020 | 0.429 | 0.003 | |
Left trunk lateral
| 0.292 | 0.266 | 0.082 | 0.384 |
0.034 | 0.054 | 0.559 | 0.004 | |
Pain | -0.205 | -0.268 | -0.101 | -0.754 |
0.040 a | 0.007 a | 0.313 a | <0.001 a | |
FSS | -0.086 | -0.039 | -0.039 | -0.426 |
0.538 | 0.780 | 0.780 | 0.001 |
rho: Spearman’s rank correlation coefficient, a Pearson correlations analyze.
FM: Fibromyalgia, FSS: Fatigue Severity Scale.
Acknowledgements: NIL .
Disclosure of Interests: None declared.
© The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (